Home NDC 23155-094 Doxazosin
Product NDC 23155-094
11-digit product format 231550094
Labeler code 23155
Product ID 23155-094_cf1c14bc-a5cc-4800-9ec8-d5fbe267c43c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Doxazosin
Dosage form TABLET
Route ORAL
Labeler Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Application ANDA205210
Marketing category ANDA
Marketing start 2018-02-13
Substance DOXAZOSIN MESYLATE
Active strength 4 mg/1
Pharmacologic classes Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 23155-094 I Inactivated by FDA excluded / ndc_excluded.zip 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 23155-094 23155-094-01 I Inactivated by FDA excluded / ndc_excluded.zip 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A205210-001 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 A205210-002 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 A205210-003 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 A205210-004 DOXAZOSIN MESYLATE DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205210-001 DOXAZOSIN MESYLATE EQ 1MG BASE TABLET / ORAL AB 2018-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205210-002 DOXAZOSIN MESYLATE EQ 2MG BASE TABLET / ORAL AB 2018-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205210-003 DOXAZOSIN MESYLATE EQ 4MG BASE TABLET / ORAL AB 2018-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205210-004 DOXAZOSIN MESYLATE EQ 8MG BASE TABLET / ORAL AB 2018-02-13 d8e5a09893c0…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 168 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Doxazosin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DOXAZOSIN MESYLATE 4 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 86P6PQK0MU Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 197625 Internal RxNorm lookup 197626 Internal RxNorm lookup 197627 Internal RxNorm lookup 197628 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 23155-094-01 Doxazosin 100 in 1 BOTTLE TABLET 100 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 23155-094 DOXAZOSIN TABLET [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] 9 Current NDC, Legacy NDC, 1 package rows 20240705_7991373e-8a62-47f9-b4fb-90573485af4e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 23155-094-01 23155009401 100 TABLET in 1 BOTTLE (23155-094-01) 100 tablet 2018-02-13 0000-00-00 No No Current